Differential expression and DNA methylation of angiotensin type 1A receptors in vascular tissues during genetic hypertension development
GLP-1 also slows the stomach emptying, leading to a feeling of fullness and reduced hunger
Clinical & Scientific References 1 Mifflin MD, St Jeor ST, Hill LA, et al
Editorial Advisory Board Member, Harvard Health Publishing The GLP-1 drugs, which include semaglutide (Ozempic, Rybelsus, Wegovy) and tirzepatide (Mounjaro, Zepbound), are turning out to have effects that go beyond shedding pounds and controlling diabetes
Consistently, an indirect inhibition of intestinal FXR through microbiota modulation, or genetic deletion of intestinal FXR, corroborate this phenome displaying protection from high-fat diets induced obesity and fatty liver disease (351)